이 팟캐스트 소개 🔗

업데이트 빈도:
every 21 days
평균 오디오 길이:
53 minutes
게스트 인터뷰
비디오 팟캐스트
영어
미국
에피소드 11 개
2025년 8월 1일부터
episodic

최신 에피소드 🔗

Lindsay Edwards went from producing UK top ten singles with Sting and Whitney Houston to pioneering the first data science group at GSK — and he's carried the same creative instinct into machine learning ever since. Now CTO of Relation Therapeutics, he's one of the clearest-eyed voices in the indus…

과거 에피소드 검색

Transcribed의 과거 에피소드를 검색하세요.

이전 에피소드

Jacob Berlin spent years perfecting a microarray chip the size of a fingernail before he thought about starting a company. Now, as cofounder and CEO of Terray Therapeutics, he's using that hardware to generate chemistry data at a scale the industry has never seen, and arguing that models without pr…
Kate Haviland knows how to push through clinical setbacks and turn breakthrough science into life-changing therapies. As former CEO of Blueprint Medicines, she led the team that took Ayvakit from a failed Phase 3 to a $500M blockbuster — by cutting the dose by 87% and betting on a patient populatio…
Janice Chen cofounded Mammoth Biosciences straight out of Jennifer Doudna's lab — and she's been rewriting the CRISPR playbook ever since. In this episode, she tells host and Benchling CEO Sajith Wickramasekara about what it really takes to build a platform company, why the biggest barriers to ge…
Nicole Paulk talks about turning moonshots into companies, why unpopular ideas are the right ones to pursue, and how biotech has to move faster and cheaper to survive.
Gleb Kuznetsov talks about about ditching Google for grad school, what it takes to build a true platform company, and where AI-driven drug discovery is headed.
Andrew Bellinger discusses what it takes to build new drug modalities from scratch, the bold bets and tough calls that shaped Verve’s journey, and lessons in building new companies from first-in-class science. * Editor's note: The interview was recorded following the announcement of Verve's acquisi…
Jake Becraft reflects on making bold bets in mRNA, the journey from lab bench to biotech founder, and the state of science today. (00:00) Introduction to Jake Becraft (00:39) Betting big on mRNA — before it was a proven modality (11:34) Getting your drugs to patients (25:47) The state of modern bio…
Karen Akinsanya unpacks the rise of computational drug discovery, what it takes to prove impact of new technologies, and the importance of setting realistic expectations for AI. (00:00) Introduction to Karen Akinsanya (01:54) Pursuing big technological shifts (06:24) How computation is setting the …
Sara Kenkare-Mitra talks about resilience, risk, and the kind of leadership it takes to save failing drug programs — and make medicines that matter. (00:00) Introduction to Sara Kenkare-Mitra (00:36) Turning a (nearly) failed program into a bestselling drug (08:33) Learning from industry legends (2…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Benchling에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.